Can normal HbA1c, fasting insulin, triglycerides, and triglyceride-to-HDL ratio miss short nocturnal glucose dips without CGM?

Standard clinical assessments often overlook overnight glycemic fluctuations, which can occur even in individuals with optimal metabolic health.

Clinical limitations of static markers

• Insensitivity to dynamic changes: Standard daytime parameters—including HbA1c, fasting insulin, triglycerides, and the triglyceride-to-HDL ratio—reflect average glycemic states or fasting baselines but cannot detect acute, short-term overnight fluctuations.
• Undetected nocturnal dips: Approximately 14% of healthy, non-diabetic individuals with optimal metabolic profiles experience transient nocturnal glucose dips below 54 mg/dL. These brief, asymptomatic events are invisible to static blood draws and require the temporal granularity of continuous glucose monitoring (CGM) metrics, such as Time Below Range (TBR), to be detected.

Mechanistic explanations and artifacts

• Glycemic variability: Higher daytime and overall glycemic variability (characterized by wide daily fluctuations) strongly correlates with and predicts the occurrence and severity of true nocturnal glucose drops.
• Compression hypoglycemia: Physical pressure on the CGM sensor during sleep reduces localized interstitial fluid flow. This artifact causes sharp, false overnight drops in glucose readings, mimicking true physiological hypoglycemia.

Bottom line

• Static daytime biomarkers are blind to overnight glucose dynamics. While CGM is essential to detect transient nocturnal dips, readings must be carefully evaluated to distinguish true physiological dips (driven by overall glycemic variability) from sleep-position compression artifacts.